For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style S ...

Quest Diagnostics (DGX) is gaining from advanced diagnostics offerings and strategic acquisitions. Rising debts and industry challenges continue to dent growth. The stock carries a Zacks Rank #3 (Hold).Factors Driving DGX StockQuest Diagnostics’ growth in the Physician Lab Services is backed by new customer wins, growing utilization of the company’s Advanced Diagnostics portfolio and contributions from acquisitions. The ongoing strength in healthcare utilization boosted growth throughout 2024. Quest Diagnos ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.It also includes access to the Zacks Style Scores. What a ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even higher." With this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving that way. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.Even though momentum is a popular stock char ...

SECAUCUS, N.J., Jan. 30, 2025 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that it has been selected as one of the 2025 World's Most Admired Companies™ by Fortune® magazine, the 11th consecutive year the company has been named to the elite list of globally respected companies.The selection is based on nine key attributes related to corporate reputation, including quality of products and services, innovation, community responsibility, s ...

Quest Diagnostics (DGX 5.62%) stock was teasing its all-time high on Thursday, no mean feat for a company that's been publicly traded for decades. The healthcare testing specialist's share price was up by more than 5% in late afternoon action, well ahead of the S&P 500 index's 0.8% gain at that point in the day. Notching a double beatThe main reason for the bullish move wasn't hard to figure out -- Quest posted its fourth-quarter and full-year 2024 results this morning. Investors were particularly impressed ...

Quest Diagnostics saw robust growth in earnings and revenue, surpassing expectations for Q4 2024.Quest Diagnostics (DGX 5.67%), a leader in diagnostic testing and information services, released its fourth quarter results on Jan. 30. The company reported a notable quarter with adjusted earnings per share (EPS) of $2.23, surpassing the analyst projection of $2.18. Additionally, revenue reached $2.62 billion, exceeding the expected $2.58 billion. Overall, Quest had a successful quarter, driven by strategic acq ...

Quest Diagnostics Inc.’s (DGX) fourth-quarter 2024 adjusted earnings per share (EPS) of $2.23 beat the Zacks Consensus Estimate by 1.8%. The metric also exceeded the year-ago adjusted figure by 3.7%.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Certain one-time expenses, like the ones related to amortization expenses, certain restructuring and integration charges, other expenses and excess tax benefits associated with stock-based compensations, were excluded from the quarter’s adjus ...

Quest Diagnostics (DGX) came out with quarterly earnings of $2.23 per share, beating the Zacks Consensus Estimate of $2.19 per share. This compares to earnings of $2.15 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.83%. A quarter ago, it was expected that this medical laboratory operator would post earnings of $2.26 per share when it actually produced earnings of $2.30, delivering a surprise of 1.77%.Over the last four qua ...

Exhibit 99.1 Quest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share SECAUCUS, N.J., January 30, 2025 -- Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, 2024. "In the fourth quarter, we delivered impressive revenue growth of nearly 15%, including approximat ...